Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
Launched by KANSAS CITY HEART RHYTHM RESEARCH FOUNDATION · Dec 2, 2021
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Myocarditis Causing Premature Ventricular Contractions: Insights From the MAVERIC Registry" is looking into the connection between a condition called myocarditis, which is inflammation of the heart muscle, and premature ventricular contractions (PVCs), which are extra heartbeats that can sometimes lead to heart rhythm problems. The study aims to understand how this inflammation may relate to PVCs, especially in patients who may or may not have reduced heart function.
To participate in this trial, you need to be over 18 years old and have experienced a significant number of PVCs, specifically 5,000 or more in a day. However, there are some health conditions that would exclude you from joining, such as a history of heart attacks or severe heart disease. If you qualify, you will undergo thorough testing to help determine if myocarditis is linked to your heart issues. It's important to note that this trial is not yet recruiting participants, so you would need to wait until it begins to find out more about getting involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients \> 18 years of age with mono-morphic or polymorphic PVC burden of ≥5000 in 24 hours.
- • Non-sustained VT was defined as ≥3 more consecutive beats lasting \<30 seconds
- Exclusion Criteria:
- • History of myocardial infarction,
- • Significant flow-limiting coronary artery disease (≥50% stenosis) on invasive coronary angiography or CT angiography,
- • History of revascularization,
- • Significant symptomatic atrial arrhythmias associated with LV dysfunction,
- • Severe valvular disease,
- • Cardiomyopathy attributed to toxins such as alcohol and illicit drugs,
- • History of cardiac arrest,
- • History of channelopathies or inherited arrhythmias.
About Kansas City Heart Rhythm Research Foundation
The Kansas City Heart Rhythm Research Foundation is a leading clinical research organization dedicated to advancing the understanding and treatment of heart rhythm disorders. With a focus on innovative research methodologies and patient-centered care, the foundation conducts rigorous clinical trials aimed at improving therapeutic options for patients with arrhythmias. Committed to collaboration with healthcare professionals and leveraging cutting-edge technology, the foundation strives to enhance clinical outcomes and contribute to the development of evidence-based practices in cardiology. Through its initiatives, the Kansas City Heart Rhythm Research Foundation plays a vital role in shaping the future of heart rhythm management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Overland Park, Kansas, United States
Patients applied
Trial Officials
Dhanunjaya Lakkireddy, MD
Principal Investigator
Kansas City Heart Rhythm Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials